Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Recruiting1
Other3

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT06405607Phase 2Recruiting
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
Alcohol AbuseAlcohol DependenceAlcohol Use Disorder
PrincipalinvestigatorStart date: 2025-06-12
NCT05421065Phase 2Active Not Recruiting
Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder
Alcohol Use Disorder
PrincipalinvestigatorStart date: 2024-02-02
NCT05707663Active Not Recruiting
Longitudinal Assessment of Brain Structure and Function in Juvenile-onset Huntington's Disease
Juvenile Huntington DiseaseJuvenile-Onset Huntington Disease
PrincipalinvestigatorStart date: 2020-01-01
Clinical Trial Readiness for SCA1 and SCA3
Spinocerebellar Ataxia 3Spinocerebellar Ataxia Type 1
PrincipalinvestigatorStart date: 2018-08-16
NCT01860339Completed
Child to Adult Neurodevelopment in Gene Expanded Huntington's Disease
Huntington's Disease
PrincipalinvestigatorStart date: 2005-07-01

Research Network

Collaboration Network

32 collaborators·78 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

George Wilmot, MD, PhD

Emory University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Talene Yacoubian, MD, PhD

University of Alabama at Birmingham

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Puneet Opal, MD, PhD

Northwestern University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

SH Subramony, MD

University of Florida

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Haris I Sair, MD

Johns Hopkins University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Peter Morrison, DO

University of Rochester

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Vikram Shakkottai, MD, PhD

University of Texas

Related
2 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Peter Barker, MD

Johns Hopkins University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Chiadikaobi Onyike, MD

Johns Hopkins University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Sharon Sha

Stanford University

Related
1 trials

Shared therapeutic areas:

Machado-Joseph DiseaseSpinocerebellar Ataxia Type 1

Worked with same sponsors:

Columbia UniversityEmory University+21 more
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06405607Phase 2PrincipalInvestigator

Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial

Alcohol AbuseAlcohol DependenceAlcohol Use Disorder
Recruiting
NCT05421065Phase 2PrincipalInvestigator

Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder

Alcohol Use Disorder
Active Not Recruiting
NCT05707663PrincipalInvestigator

Longitudinal Assessment of Brain Structure and Function in Juvenile-onset Huntington's Disease

Juvenile Huntington DiseaseJuvenile-Onset Huntington Disease
Active Not Recruiting
NCT03487367PrincipalInvestigator

Clinical Trial Readiness for SCA1 and SCA3

Spinocerebellar Ataxia 3Spinocerebellar Ataxia Type 1
Unknown
NCT01860339PrincipalInvestigator

Child to Adult Neurodevelopment in Gene Expanded Huntington's Disease

Huntington's Disease
Completed

All 5 trials loaded